We are live on ! Find out more
EC

EntryPoint Capital Portfolio holdings

AUM $341M
1-Year Est. Return 20.57%
This Fund
S&P 500
This Quarter Est. Return
+8.02%
1 Year Est. Return
+20.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$176M
AUM Growth
+$107M
Cap. Flow
+$103M
Cap. Flow %
58.75%
Top 10 Hldgs %
4.24%
Holding
1,234
New
413
Increased
180
Reduced
1
Closed
640

Top Buys

Rank Stock Value
1
GH icon
Guardant Health
GH
+$895K
2
PLAB icon
Photronics
PLAB
+$774K
3
EW icon
Edwards Lifesciences
EW
+$755K
4
MMS icon
Maximus
MMS
+$754K
5
TTEK icon
Tetra Tech
TTEK
+$745K

Top Sells

Rank Stock Value
1
DK icon
Delek US
DK
+$197K
2
CSGP icon
CoStar Group
CSGP
+$197K
3
VIST icon
Vista Energy
VIST
+$197K
4
SKX
Skechers
SKX
+$196K
5
ALRS icon
Alerus Financial
ALRS
+$195K

Sector Composition

Rank Sector Weight
1 Healthcare 19.45%
2 Technology 17.59%
3 Industrials 17.43%
4 Consumer Discretionary 12.31%
5 Financials 10.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DOV icon
751
Dover
DOV
$27.2B
– –
-109
Closed -$19.7K
DRI icon
752
Darden Restaurants
DRI
$22.5B
– –
-967
Closed -$146K
DTM icon
753
DT Midstream
DTM
$14.9B
– –
-974
Closed -$69.2K
DUOL icon
754
Duolingo
DUOL
$5.7B
– –
-557
Closed -$116K
DVN icon
755
Devon Energy
DVN
$51.9B
– –
-3,434
Closed -$163K
DXCM icon
756
DexCom
DXCM
$27.6B
– –
-1,129
Closed -$128K
DYN icon
757
Dyne Therapeutics
DYN
$4.04B
– –
-2,479
Closed -$87.5K
EHC icon
758
Encompass Health
EHC
$11.2B
– –
-435
Closed -$37.3K
EIG icon
759
Employers Holdings
EIG
$908M
– –
-3,652
Closed -$156K
ELVN icon
760
Enliven Therapeutics
ELVN
$3.78B
– –
-241
Closed -$5.63K
ENOV icon
761
Enovis
ENOV
$1.56B
– –
-1,874
Closed -$84.7K
ENVA icon
762
Enova International
ENVA
$5.91B
– –
-2,733
Closed -$170K
EOLS icon
763
Evolus
EOLS
$394M
– –
-5,401
Closed -$58.6K
EPR icon
764
EPR Properties
EPR
$4.86B
– –
-1,415
Closed -$59.4K
EQIX icon
765
Equinix
EQIX
$107B
– –
-210
Closed -$159K
EQR icon
766
Equity Residential
EQR
$25.4B
– –
-799
Closed -$55.4K
EMBJ
767
Embraer S.A. ADS
EMBJ
$11.6B
– –
-90
Closed -$2.32K
ES icon
768
Eversource Energy
ES
$28.2B
– –
-721
Closed -$40.9K
ESNT icon
769
Essent Group
ESNT
$6.06B
– –
-258
Closed -$14.5K
ESQ icon
770
Esquire Financial Holdings
ESQ
$1.04B
– –
-371
Closed -$17.7K
ESS icon
771
Essex Property Trust
ESS
$18.9B
– –
-402
Closed -$109K
ETD icon
772
Ethan Allen Interiors
ETD
$581M
– –
-6,641
Closed -$185K
EVER icon
773
EverQuote
EVER
$886M
– –
-8,292
Closed -$173K
EXC icon
774
Exelon
EXC
$48.6B
– –
-2,070
Closed -$71.6K
EXP icon
775
Eagle Materials
EXP
$6.6B
– –
-72
Closed -$15.7K
29 30
31
32 33

Similar funds

SFA
Seneca Financial Advisors Rochester, New York $341M AUM 14.73% 1-Year Est. Return
FCM
Findell Capital Management New York $341M AUM 135.6% 1-Year Est. Return
CPI
Crestview Partners II New York $341M AUM 17.29% 1-Year Est. Return
SW
SMART Wealth Omaha, Nebraska $341M AUM 24.37% 1-Year Est. Return
MTIC
Missouri Trust & Investment Company Springfield, Missouri $341M AUM 17.31% 1-Year Est. Return
KFSC
Keystone Financial Services (Colorado) Loveland, Colorado $341M AUM 18.11% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
SC
Slotnik Capital Dallas, Texas $342M AUM 105.92% 1-Year Est. Return

EntryPoint Capital's Q3 2024 Portfolio in Review

As of Q3 2024, EntryPoint Capital held 1,234 positions worth $176M, up 157% from $68.4M the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.

EntryPoint Capital deployed $103M of net new capital in Q3 2024, opening 413 new positions and adding to 180 existing holdings. Its largest new stake was Guardant Health: 31,633 shares worth $726K.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iRadimed, an estimated $8.4K trimmed.

  • EntryPoint Capital's largest Q3 2024 buy was Guardant Health: 31,633 shares worth $726K.
  • EntryPoint Capital added most to Edwards Lifesciences in Q3 2024, an estimated $755K increase.
  • EntryPoint Capital's biggest Q3 2024 reduction was iRadimed, cutting an estimated $8.4K.
  • EntryPoint Capital fully exited Delek US in Q3 2024, selling an estimated $197K.
  • EntryPoint Capital's ten largest holdings make up 4.2% of its $176M portfolio in Q3 2024.
  • EntryPoint Capital opened 413 new positions and closed 640 in Q3 2024.
  • EntryPoint Capital's portfolio value rose 157% quarter-over-quarter to $176M.

Based on EntryPoint Capital's 13F filing for Q3 2024, filed 13 Nov 2024.